Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Hauts-de-France And NotJean Sibilia

List of bibliographic references

Number of relevant bibliographic references: 28.
Ident.Authors (with country if any)Title
000289 Ibrahim Yakoub-Agha [France] ; Christian Chabannon [France] ; Peter Bader [Allemagne] ; Grzegorz W. Basak [Pologne] ; Halvard Bonig [Allemagne] ; Fabio Ciceri [Italie] ; Selim Corbacioglu [Allemagne] ; Rafael F. Duarte [Espagne] ; Hermann Einsele [Allemagne] ; Michael Hudecek [Allemagne] ; Marie José Kersten [Pays-Bas] ; Ulrike Köhl [Allemagne] ; Jürgen Kuball [Pays-Bas] ; Stephan Mielke [Suède] ; Mohamad Mohty [France] ; John Murray [Royaume-Uni] ; Arnon Nagler [Israël] ; Stephen Robinson [Royaume-Uni] ; Riccardo Saccardi [Italie] ; Fermin Sanchez-Guijo [Espagne] ; John A. Snowden [Royaume-Uni] ; Micha Srour [France] ; Jan Styczynski [Pologne] ; Alvaro Urbano-Ispizua [Espagne] ; Patrick J. Hayden [Irlande (pays)] ; Nicolaus Kröger [Allemagne]Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
000487 Siddharth Singh ; Mathurin Fumery [France] ; Abha G. Singh ; Namrata Singh [États-Unis] ; Larry J. Prokop [États-Unis] ; Parambir S. Dulai ; William J. Sandborn ; Jeffrey R. CurtisComparative Risk of Cardiovascular Events With Biologic and Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
000727 Jean Darloy [France] ; Nicolas Segaud [France] ; Jean-Hugues Salmon [France] ; Jean-Paul Eschard [France] ; Vincent Goëb [France] ; Xavier Deprez [France] ; Marie-Hélène Guyot [France] ; Eric Houvenagel [France] ; Nicolas Lecuyer [France] ; Laurent Marguerie [France] ; Samuel Gally [France] ; David Pau [France] ; Isabelle Idier [France] ; Guy Baudens [France] ; René-Marc Flipo [France]Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study
000A26 Frederike C. Oertel [Allemagne] ; Olivier Outteryck [France] ; Benjamin Knier [Allemagne] ; Hanna Zimmermann [Allemagne] ; Nadja Borisow [Allemagne] ; Judith Bellmann-Strobl [Allemagne] ; Astrid Blaschek [Allemagne] ; Sven Jarius [Allemagne] ; Markus Reindl [Autriche] ; Klemens Ruprecht [Allemagne] ; Edgar Meinl [Allemagne] ; Reinhard Hohlfeld [Allemagne] ; Friedemann Paul [Allemagne] ; Alexander U. Brandt [Allemagne, États-Unis] ; Tania Kümpfel [Allemagne] ; Joachim Havla [Allemagne]Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study
000F94 Amayelle Rey [France] ; Benjamin Batteux [France] ; Solène M. Laville [France] ; Justine Marienne [France] ; Kamel Masmoudi [France] ; Valérie Gras-Champel [France] ; Sophie Liabeuf [France]Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study
001315 Frits Van Rhee [États-Unis] ; Peter Voorhees [États-Unis] ; Angela Dispenzieri [États-Unis] ; Alexander Foss [Norvège] ; Gordan Srkalovic [États-Unis] ; Makoto Ide [Japon] ; Nikhil Munshi [États-Unis] ; Stephen Schey [Royaume-Uni] ; Matthew Streetly [Royaume-Uni] ; Sheila K. Pierson [États-Unis] ; Helen L. Partridge [États-Unis] ; Sudipto Mukherjee [États-Unis] ; Dustin Shilling [États-Unis] ; Katie Stone [États-Unis] ; Amy Greenway [États-Unis] ; Jason Ruth [États-Unis] ; Mary Jo Lechowicz ; Shanmuganathan Chandrakasan [États-Unis] ; Raj Jayanthan [États-Unis] ; Elaine S. Jaffe [États-Unis] ; Heather Leitch [Canada] ; Naveen Pemmaraju [États-Unis] ; Amy Chadburn [États-Unis] ; Megan S. Lim ; Kojo S. Elenitoba-Johnson ; Vera Krymskaya [États-Unis] ; Aaron Goodman [États-Unis] ; Christian Hoffmann [Allemagne] ; Pier Luigi Zinzani [Italie] ; Simone Ferrero [Italie] ; Louis Terriou [France] ; Yasuharu Sato [Japon] ; David Simpson [Nouvelle-Zélande] ; Raymond Wong [Hong Kong] ; Jean-Francois Rossi [France] ; Sunita Nasta [États-Unis] ; Kazuyuki Yoshizaki [Japon] ; Razelle Kurzrock [États-Unis] ; Thomas S. Uldrick [États-Unis] ; Corey Casper [États-Unis] ; Eric Oksenhendler [France] ; David C. Fajgenbaum [États-Unis]International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
001641 Sarah Salomon [France] ; Caroline Guignant [France] ; Pierre Morel [France] ; Gauthier Flahaut [France] ; Clément Brault [France] ; Clément Gourguechon [France] ; Patrice Fardellone [France] ; Jean-Pierre Marolleau [France] ; Brigitte Gubler [France] ; Vincent Goëb [France]Th17 and CD24hiCD27+ regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis
001736 L. Méry-Bossard [France] ; K. Bagny [France] ; G. Chaby [France] ; A. Khemis [France] ; F. Maccari [France] ; H. Marotte [France] ; J L Perrot [France] ; Z. Reguiai [France] ; M L Sigal [France] ; M. Avenel-Audran [France] ; T. Boyé [France] ; A. Grasland [France] ; J. Gillard [France] ; D. Jullien [France] ; E. Toussirot [France]New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases.
001884 Arsene Mekinian [France] ; Guillaume Dervin [France] ; Nathanael Lapidus [France] ; Jean-Emmanuel Kahn [France] ; Louis Terriou [France] ; Eric Liozon [France] ; Eric Grignano [France] ; Jean-Charles Piette [France] ; Odile Beyne Rauzy [France] ; Vincent Grobost [France] ; Pascal Godmer [France] ; Jerome Gillard [France] ; Julien Rossignol [France] ; David Launay [France] ; Achille Aouba [France] ; Thierry Cardon [France] ; Laurence Bouillet [France] ; Jonathan Broner [France] ; Julien Vinit [France] ; Lionel Ades [France] ; Fabrice Carrat [France] ; Clementine Salvado [France] ; Eric Toussirot [France] ; Mathilde Versini [France] ; Nathalie Costedoat-Chalumeau [France] ; Jean Baptiste Fraison [France] ; Philippe Guilpain [France] ; Pierre Fenaux [France] ; Olivier Fain [France]Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patients.
001902 Marie Desplats [France] ; Tristan Pascart [France] ; Germain Jelin [France] ; Laurène Norberciak [France] ; Peggy Philippe [France] ; Eric Houvenagel [France] ; Vincent Goeb [France] ; René-Marc Flipo [France]Are abatacept and tocilizumab intravenous users willing to switch for the subcutaneous route of administration? A questionnaire-based study.
001944 M. Jouvray [France] ; L. Terriou [France] ; V. Meignin [France] ; B. Bouchindhomme [France] ; M. Jourdain [France] ; M. Lambert [France] ; G. Lefevre [France] ; E. Hachulla [France] ; P-Y Hatron [France] ; L. Galicier [France] ; D. Launay [France][Pseudo-adult Still's disease, anasarca, thrombotic thrombocytopenic purpura and dysautonomia: An atypical presentation of multicentric Castleman's disease. Discussion of TAFRO syndrome].
001A77 Éric Toussirot [France] ; Antoine Martin [France] ; Martin Soubrier [France] ; Serge Redeker [France] ; Alexis Régent [France]Rapid and Sustained Response to Tocilizumab in Patients with Polymyalgia Rheumatica Resistant or Intolerant to Glucocorticoids: A Multicenter Open-label Study.
001B58 Coline Faivre [France] ; Axel Patrice Villani [France] ; François Aubin [France] ; Dan Lipsker [France] ; Martine Bottaro [France] ; Jean-David Cohen [France] ; François Durupt [France] ; Géraldine Jeudy [France] ; Emilie Sbidian [France] ; Eric Toussirot [France] ; Valérie Badot [Belgique] ; Sébastien Barbarot [France] ; Sébastien Debarbieux [France] ; Emmanuel Delaporte [France] ; Guetty Goegebeur [France] ; Jacques Morel [France] ; Aude Nassif [France] ; Gérard Duru [France] ; Denis Jullien [France]Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases.
001C05 Marie Fechtenbaum [France] ; Pauline Lasselin-Boyard ; Sarah Salomon ; Germain Jelin ; Florence Millot ; Franck Grados ; Patrice Fardellone ; Vincent GoëbDecrease of Tocilizumab Dose in Patients with Rheumatoid Arthritis: A Pilot Study.
001C31 Franck Patin [France] ; Thomas Baranek [France] ; Patrick Vourc [France] ; Lydie Nadal-Desbarats [France] ; Jean-François Goossens [France] ; Sylviane Marouillat [France] ; Anne-Frédérique Dessein [France] ; Amandine Descat [France] ; Blandine Madji Hounoum [France] ; Clément Bruno [France] ; Hervé Watier [France] ; Mustafa Si-Tahar [France] ; Samuel Leman [France] ; Jean-Claude Lecron [France] ; Christian R. Andres [France] ; Philippe Corcia [France] ; Hélène Blasco [France]Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism
001D87 Tristan Pascart [France, Niger] ; Peggy Philippe [France] ; Elodie Drumez [France] ; Xavier Deprez [France] ; Bernard Cortet [France] ; Alain Duhamel [France] ; Eric Houvenagel [France] ; René-Marc Flipo [France]Comparative efficacy of tocilizumab, abatacept and rituximab after non‐TNF inhibitor failure: results from a multicentre study
001E48 Marie Fechtenbaum [France] ; Christopher Banse [France] ; Pauline Boyard-Lasselin [France] ; Vincent Goëb [France]Toxidermia under treatment with tocilizumab for rheumatoid arthritis.
002005 Clara Leroy [France] ; Jean-Marc Rigot [France] ; Maryse Leroy [France] ; Christine Decanter [France] ; Kristell Le Mapihan [France] ; Anne-Sophie Parent [France] ; Anne-Claire Le Guillou [France] ; Ibrahim Yakoub-Agha [France] ; Sébastien Dharancy [France] ; Christian Noel [France] ; Marie-Christine Vantyghem [France]Immunosuppressive drugs and fertility
002067 Ciara L. Freeman [Royaume-Uni] ; Franck Morschhauser [France] ; Laurie Sehn [Canada] ; Mark Dixon [Royaume-Uni] ; Richard Houghton [Royaume-Uni] ; Thierry Lamy [France] ; Günter Fingerle-Rowson [Suisse] ; Elisabeth Wassner-Fritsch [Suisse] ; John G. Gribben [Royaume-Uni] ; Michael Hallek [Allemagne] ; Gilles Salles [France] ; Guillaume Cartron [France]Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions
002492 Patrice Fardellone [France] ; Alice Séjourné [France] ; Julien Paccou [France] ; Vincent Goëb [France]Bone Remodelling Markers in Rheumatoid Arthritis
002C33 Alessandra Blaizot [France] ; Paul Monsarrat [France] ; Arnaud Constantin [France] ; Jean-Noel Vergnes [France] ; Gabriel Fernandez De Grado [France] ; Cathy Nabet [France] ; Alain Cantagrel [France] ; Michel Sixou [France]Oral health‐related quality of life among outpatients with rheumatoid arthritis
002D81 A. Meyer [France] ; G. Lefevre ; A. Tournadre ; B. Le Goff ; S. Ottaviani [France] ; A.-L. Buchdahl ; M. De Brandt [France] ; P. Coquerelle [France] ; R.-M. Flipo ; G. Falgarone [France] ; G. Bernard [France] ; Z. Amoura [France] ; O. Benveniste [France] ; J. Sibilia [France] ; E. Hachulla ; B. Hervier [France]FRI0381 During antisynthetase syndrome, anti-citrullinated peptides are a marker of severe joint disease
002E30 A.-P. Trouvin ; S. Jacquot ; S. Grigioni ; H. Boulard ; I. Dutot ; O. Vittecoq ; X. Le Loet ; O. Boyer ; V. Goeb [France]FRI0215 Transitional and memory b cell analysis is an essential tool to anticipate clinical relapse in rheumatoid arthritis (RA) patients treated with rituximab
003560 J E Gottenberg [France] ; P. Ravaud [France] ; A. Cantagrel [France] ; B. Combe [France] ; R M Flipo [France] ; T. Schaeverbeke [France] ; E. Houvenagel [France] ; P. Gaudin [France] ; D. Loeuille [France] ; S. Rist [France] ; M. Dougados [France] ; J. Sibilia [France] ; X. Le Loët [France] ; C. Marcelli [France] ; T. Bardin [France] ; I. Pane [France] ; G. Baron [France] ; X. Mariette [France]Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry
003A61 T. Burnouf [France]Recombinant plasma proteins
003B22 Brahim Selmaoui [France] ; Jacques Lambrozo [France] ; Linda Sackett-Lundeen [États-Unis] ; Erhard Haus [États-Unis] ; Yvan Touitou [France]Acute Exposure to 50-Hz Magnetic Fields Increases Interleukin-6 in Young Healthy Men
003F81 O. Meyer [France] ; H. Charlanne [France] ; P. Cherin [France] ; Y. Allanore [France] ; P. Coquerelle [France] ; B. Grardel [France] ; A-M Chamot [Suisse] ; E. Hachulla [France]Subluxing arthropathy: an unusual manifestation of the antisynthetase syndrome
004401 Alain Saraux [France] ; Stéphanie Rouanet [France] ; René-Marc Flipo [France] ; Jean-Cyril Poncet [France] ; Patrice Fardellone [France] ; Pascal Hilliquin [France] ; Isabelle Idier [France] ; Alain Cantagrel [France]Glucocorticoid-sparing in patients suffering from rheumatoid arthritis and treated with tocilizumab: the SPARE-1 study.

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021